Showing results (101-110 of 213) with videos related to
Sort By:
Pageof 22
Lancet (London, England)|April 3, 1976
Pituitary function in patients receiving intermittent cytotoxic and corticosteroid therapy for malignant lymphomaA Naysmith, B W Hancock, D R Cullen, et al.Gynecologic Oncology|September 14, 2000
Characteristics of women with recurrent molar pregnanciesP C Lorigan, S Sharma, N Bright, et al.British Journal of Cancer|September 1, 1977
Follow-up studies on the immune status of patients with Hodgkin's disease after splenectomy and treatment, in relapse and remissionB W Hancock, L Bruce, I R Dunsmore, et al.International Journal of Oncology|November 24, 1998
Localised non-Hodgkin's lymphoma: the Sheffield Lymphoma Group experience (1970-1995)L S Dobson, H Hancock, N Bright, et al.European Journal of Cancer & Clinical Oncology|March 1, 1982
Serum ferritin as a third marker in germ cell tumoursA Grail, G Bates, A M Ward, et al.International Journal of Oncology|June 26, 2008
Poor outcome in adolescents with high-risk Hodgkin lymphomaR A Herbertson, L S Evans, J Hutchinson, et al.European Journal of Pharmacology|October 8, 1985
Alpha 2-adrenoceptor coupling to adenylate cyclase in adrenaline insensitive human plateletsS S Swart, M Maguire, J K Wood, et al.Hepato-Gastroenterology|May 3, 2000
Increased risk of infection with Helicobacter pylori in spouses of infected subjects: observations in a general population sample from the UKM A Stone, N Taub, D B Barnett, et al.Thrombosis Research|March 1, 1984
Functional significance of the platelet alpha2-adrenoceptor: studies in patients with myeloproliferative disordersS S Swart, D Pearson, J K Wood, et al.British Journal of Clinical Pharmacology|March 29, 2012
Bioavailability of commercial tetracycline productsD B Barnett, R N Smith, N D Greenwood, et al.Pageof 22